RRD International has launched a new brand—RRD Biopharma Development—reflecting its unique offering of delivering strategy-driven product development services to biopharmaceutical companies and investors. 
 
The rebrand includes a new updated website showcasing its Product Development Team (PDT) Model, which is designed to enable biopharma companies with limited infrastructure to navigate the challenges of drug development efficiently and effectively resulting in more predictable product development outcomes.
 
RRD’s team partner with companies globally applying their experience to accelerate drug development and reduce risk. Investing in the asset’s success, they aim to improve value and drive patient benefits.
 
The company, founded in 2002, is part of Uniphar Group, a Dublin, Ireland based international diversified healthcare services company. RRD claims its asset-centric development approach has helped create >$3.0 billion in value for its partners over the last 21 years.
 
Commenting on the rebrand, Scott Tarrant, CEO of RRD Biopharma Development said: “Our new, dynamic brand more accurately reflects and places emphasis on our development offering and the value that we deliver every day to our partners.
 
“The improved branding better communicates who we are and what we do which ultimately supports our growth and makes us a recognized development partner in the market,” Tarrant added.